Case Studies
Fast-tracking Market Entry to France
Discover how a Pharmaceutical Company can Cut 18 months off the Standard Timeline.
Fast-tracking Market Entry to France

Are you a biopharmaceutical company eager to launch your first EU-approved drug in France? Don't let the complex and lengthy process of establishing a compliant subsidiary slow you down.
Discover key insights on:
-
How a pharmaceutical company cut 18 months off the standard timeline for establishing its authorized local subsidiary in France.
-
The primary and secondary goals of rapidly setting up a compliant subsidiary and accessing local expertise without unnecessary recruitment.
-
The challenges of obtaining the "Exploitant" license and navigating the complex regulatory landscape in France.
-
The step-by-step process required to establish a subsidiary, including recruiting a Responsible Pharmacist, filing the dossier to ANSM, and more.
-
The successful outcome of entering the French market efficiently while maintaining regulatory compliance.
Download this Case Study
Discover our latest news

White Papers
5 Critical Considerations for French Market Entry
Unlock the Secrets to Success in the French Biopharma Market.

Case Studies
Early Access Programs in France
Explore Proven Strategies for a Quick Market Entry in France.

Articles
Exploitant Services in France for Pharmaceutical Companies
Discover why the Exploitant role is essential in France, and how does AzurBio Pharma support pharmaceutical companies in meeting this requirement.